BANGALORE, INDIA ¨C GlaxoSmithKline on Tuesday said it is recalling the popular heartburn medicine Zantac in all markets as a ¡°precaution,¡± days after the U.S. Food and Drug Administration found ¡°unacceptable¡± levels of probable cancer-causing impurity in the drug.
Zantac, also sold generically as ranitidine, is the latest drug in which cancer-causing impurities have been found. Regulators have been recalling some blood pressure and heart failure medicines since last year.
Britain¡¯s medicines watchdog said GlaxoSmithKline (GSK) was recalling four prescription-only Zantac medicines: a syrup, an injection and tablets of 150 and 300 milligram (mg) dosages. ()
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.